A national pharmacare program, which would see drug plans become publicly funded just as our health care system is, could actually save taxpayers in this province money a new study says. Authored by Marc-Andre Gagnon of Carleton University, the study estimates that a program could save Canadians $10.7 billion a year, and up to $166 million a year in Newfoundland and Labrador. “Right now the problem [is] the private plans,” sayd Gagnon, “which are blatantly inefficient in terms of containing drug costs.”